Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × GIST With D842V Mutated PDGFRA Gene × crenolanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Glioma 2 Recurrence 1 Glioblastoma 1 GIST With D842V Mutated PDGFRA Gene 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Advanced Solid Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02847429 2021-01-22

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

Arog Pharmaceuticals, Inc.

Phase 3 Unknown

GIST With D842V Mutated PDGFRA Gene

Data powered by HemOnc (CC BY 4.0) Colophon ⚡